# Nascent Pharma Holdings, Inc. (NASC)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NASC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 690.2K | $ -12.04M | $ 100.0K | $ 9.01M | $ -9.79M |
| 2023 | $ 2.33M | $ -10.53M | $ -1.43M | $ 9.18M | $ -1.00M |
| 2022 | $ 7.47M | $ -16.67M | $ -4.41M | $ 9.34M | $ 2.70M |
| 2021 | $ 5.47M | $ -14.47M | $ -9.56M | $ 7.28M | $ 5.62M |
| 2020 | $ 2.18M | $ -7.23M | $ -2.54M | $ 2.12M | $ 3.26M |
| 2019 | $ 2.98M | $ -5.93M | $ -5.25M | $ 132.3K | $ 6.65M |
| 2018 | $ 883.0K | $ -5.43M | $ -1.06M | $ 19.2K | $ 3.49M |
| 2017 | $ 165.4K | $ -2.88M | $ -385.7K | $ 193.5K | $ -1.73M |
| 2016 | $ 130.9K | $ -877.5K | $ -196.0K | $ 58.3K | $ -514.6K |
| 2015 | $ 155.2K | $ -1.73M | $ -531.5K | $ 5.0K | $ 103.3K |
| 2014 | $ 45.9K | $ -27.9K | $ 5.8K | $ 67.0K | $ 98.8K |
| 2013 | $ 21.7K | $ -455.8K | $ -393.5K | $ 36.4K | $ 61.4K |
| 2012 | $ 34.8K | $ -2.39M | $ -800.8K | $ 236.3K | $ 34.7K |
| 2011 | $ 1.3K | $ -1.58M | $ -419.9K | $ 213.2K | $ 1.18M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.92 |
| Liabilities / Eq | -1.19 |
| Current Ratio | 0.14 |

## Other views

- [Metrics](https://sponda.capital/en/NASC.md)
- [Charts](https://sponda.capital/en/NASC/charts.md)
- [Compare](https://sponda.capital/en/NASC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.